Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Agent Innovation Co. Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit. CRUM, MARY ABOU NADER is the busiest examiner, with 1 pending matter.
The single-channel record permits focused prosecution management. Counsel can concentrate on the biotechnology issues in the pending action and develop one consistent claim position without coordinating separate examination teams. Any amendment should address the examiner’s concern directly while remaining tied to the disclosed technical features and preserving useful scope.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRUM, MARY ABOU NADER | 1 | 39.2% | +63.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18800196 | PROBIOTICS SEPARATED FROM RABBIT FECES AND FOOD CONTAINING PROBIOTICS | CRUM, MARY ABOU NADER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18800196 | PROBIOTICS SEPARATED FROM RABBIT FECES AND FOOD CONTAINING PROBIOTICS | CRUM, MARY ABOU NADER | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18800196 | PROBIOTICS SEPARATED FROM RABBIT FECES AND FOOD CONTAINING PROBIOTICS | CRUM, MARY ABOU NADER | 1657 | §103§112 | Non-Final OA | — | Pending | Aug 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAgent Innovation Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mary Abou Nader Crum has the most, with 1 of Agent Innovation Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
